| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.8 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Type 2 Diabetes Mellitus |
0 |
0.64 |
| Renal Disease |
0 |
0.61 |
| Diabetic Nephropathy |
0 |
0.42 |
| Heart |
0 |
0.3 |
| Kidney |
0 |
0.3 |
| Diabetic Microvascular Complications |
0 |
0.23 |
| Heart Failure (HF) |
0 |
0.23 |
| Cardiovascular disease |
0 |
0.15 |
| Cardiovascular Imaging |
0 |
0.15 |
| Cardiovascular Risk Management |
0 |
0.15 |
| Ejection Fraction |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.15 |
| Type 1 Diabetes Mellitus |
0 |
0.13 |